Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria

33Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background/Aims: Limited evidence exists on the choice of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in diabetic patients with nephropathy. We aim to assess the renal effectiveness and safety of these drugs among diabetic nephropathy patients. Methods: This retrospective cohort study was conducted with diabetic nephropathy patients who initiated ACEI or ARB monotherapy. The primary outcome was a composite of end stage of renal disease and renal transplantation, and the secondary outcome was all-cause mortality. The safety endpoint was hyperkalemia. Results: Three thousand seven hundred and thirty-nine ACEI users and 3,316 ARB users were identified. ARBs seemed to be inferior to ACEIs given their poorer renal outcome (HR 1.31; 95% CI, 1.15-1.50) and higher risk of hyperkalemia (HR 1.17; 95% CI, 1.04-1.32). Among the four ACEIs compared, captopril was an inferior treatment choice given its poorer renal outcomes (HR 1.42; 95% CI, 1.05-1.93) and higher mortality rate (HR 1.25; 95% CI, 1.01-1.55). Irbesartan appeared to be a poorer treatment choice among the three ARBs compared, given its inferior renal protective effect (HR 1.35; 95% CI, 1.03-1.78). Conclusions: Our findings suggest ACEIs as a relatively more renoprotective and safer treatment as compared to ARBs. Captopril and irbesartan may be inferior to the other ACEIs and ARBs respectively.

References Powered by Scopus

Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications

1335Citations
N/AReaders
Get full text

The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments

1115Citations
N/AReaders
Get full text

Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores

1012Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy

107Citations
N/AReaders
Get full text

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: A Systematic Review and Meta-Analysis

66Citations
N/AReaders
Get full text

Inhibition of angiotensin-converting enzyme ameliorates renal fibrosis by mitigating DPP-4 level and restoring antifibrotic microRNAs

65Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hsu, F. Y., Lin, F. J., Ou, H. T., Huang, S. H., & Wang, C. C. (2017). Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria. Kidney and Blood Pressure Research, 42(2), 358–368. https://doi.org/10.1159/000477946

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 27

61%

Researcher 8

18%

Lecturer / Post doc 7

16%

Professor / Associate Prof. 2

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 30

48%

Pharmacology, Toxicology and Pharmaceut... 26

41%

Biochemistry, Genetics and Molecular Bi... 4

6%

Nursing and Health Professions 3

5%

Save time finding and organizing research with Mendeley

Sign up for free
0